Search hospitals > Florida > Miami

University of Miami Miller School of Medicine

Claim this profile
Miami, Florida 33136
Global Leader in Human Immunodeficiency Virus Infection
Global Leader in HIV Infection
Conducts research for Primary Lateral Sclerosis
Conducts research for Fibrosing Colonopathy
Conducts research for HIV/AIDS
369 reported clinical trials
24 medical researchers
Photo of University of Miami Miller School of Medicine in MiamiPhoto of University of Miami Miller School of Medicine in MiamiPhoto of University of Miami Miller School of Medicine in Miami

Summary

University of Miami Miller School of Medicine is a medical facility located in Miami, Florida. This center is recognized for care of Human Immunodeficiency Virus Infection, HIV Infection, Primary Lateral Sclerosis, Fibrosing Colonopathy, HIV/AIDS and other specialties. University of Miami Miller School of Medicine is involved with conducting 369 clinical trials across 497 conditions. There are 24 research doctors associated with this hospital, such as Sabine s Coppieters, MD, Cynthia Levy, MD, Marilyn Huang, and Craig Moskowitz, MD.

Top PIs

Clinical Trials running at University of Miami Miller School of Medicine

Lymphoma
Traumatic Brain Injury
Multiple Sclerosis
Stroke
Systemic Lupus Erythematosus
Primary Lateral Sclerosis
Bleeding Disorder
Tourette Syndrome
Lichen Simplex Chronicus
Prurigo Nodularis
Image of trial facility.

Brentuximab Vedotin

for Hodgkin Lymphoma

RADAR is a multicentre, international, randomised, open-label phase III clinical trial composed of 2 trials running in parallel. Trial 1 will be led and sponsored by University College London (UCL) and conducted in Europe and Australia/New Zealand. Trial 2 will be led by the Canadian Cancer Trials Group (CCTG) and conducted in North America, with CCTG the regulatory sponsor in Canada, and University of Miami the regulatory sponsor and IND holder in the US. Datasets from Trial 1 and Trial 2 will be combined to achieve the total sample size. Data analysis will be performed by UCL and therefore UCL is responsible for the clinicaltrials.gov entry. Eligible patients will be randomised to receive either ABVD or A2VD chemotherapy. An interim PET-CT scan will be performed after 2 cycles of treatment, which will be used to adapt subsequent treatment. Patients will receive a total of 3-4 cycles of chemotherapy and may also receive involved site radiotherapy as consolidation. Patients will be followed up for a minimum of 5 years after treatment.
Recruiting2 awards Phase 313 criteria
Image of trial facility.

Daratumumab + Chemotherapy

for Lymphoma

This trial studies how well daratumumab combined with chemotherapy works in treating patients with a specific type of lymphoma. The treatment targets cancer cells with a protein called CD38, helping the immune system attack them and stopping their growth. Daratumumab is a CD38 monoclonal antibody approved for treating relapsed/refractory and newly diagnosed multiple myeloma.
Recruiting1 award Phase < 110 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Miami Miller School of Medicine?
Where is University of Miami Miller School of Medicine located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Miami Miller School of Medicine accept?
What awards or recognition has University of Miami Miller School of Medicine received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security